OBJECTIVES: The age-associated decline in sex hormone levels in men is paralleled by an increase in cardiovascular disease and associated risk factors including low grade chronic inflammation. The objective of this analysis was to investigate the association between sex hormone levels and C-reactive protein (CRP) in a population-based sample of men. DESIGN: Population-based, cross-sectional observational survey. PARTICIPANTS: A multistage stratified design was used to recruit a random sample of 2301 racially and ethnically diverse men age 30-79 years. Blood samples were obtained on 1899 men. Analyses were conducted on 1559 men with complete data on CRP and sex hormone levels. MEASUREMENTS: High-sensitivity CRP levels. The association between CRP and sex hormone levels was assessed using multiple linear regression models. RESULTS: An inverse association was observed, in both bivariate and multivariate analyses, between CRP and total testosterone, free testosterone and SHBG levels. These associations remained statistically significant after adjusting for age, body mass index, comorbid conditions and lifestyle factors. A positive trend between oestradiol (total and free) and CRP levels was not statistically significant. CONCLUSIONS: A robust, inverse dose-response correlation between testosterone and SHBG levels with CRP levels provides further evidence of a potential role of androgens in inflammatory processes.
OBJECTIVES: The age-associated decline in sex hormone levels in men is paralleled by an increase in cardiovascular disease and associated risk factors including low grade chronic inflammation. The objective of this analysis was to investigate the association between sex hormone levels and C-reactive protein (CRP) in a population-based sample of men. DESIGN: Population-based, cross-sectional observational survey. PARTICIPANTS: A multistage stratified design was used to recruit a random sample of 2301 racially and ethnically diverse men age 30-79 years. Blood samples were obtained on 1899 men. Analyses were conducted on 1559 men with complete data on CRP and sex hormone levels. MEASUREMENTS: High-sensitivity CRP levels. The association between CRP and sex hormone levels was assessed using multiple linear regression models. RESULTS: An inverse association was observed, in both bivariate and multivariate analyses, between CRP and total testosterone, free testosterone and SHBG levels. These associations remained statistically significant after adjusting for age, body mass index, comorbid conditions and lifestyle factors. A positive trend between oestradiol (total and free) and CRP levels was not statistically significant. CONCLUSIONS: A robust, inverse dose-response correlation between testosterone and SHBG levels with CRP levels provides further evidence of a potential role of androgens in inflammatory processes.
Authors: Johan Arnlöv; Michael J Pencina; Shreyasee Amin; Byung-Ho Nam; Emelia J Benjamin; Joanne M Murabito; Thomas J Wang; Philip E Knapp; Ralph B D'Agostino; Shalendar Bhasin; Ramachandran S Vasan Journal: Ann Intern Med Date: 2006-08-01 Impact factor: 25.391
Authors: Majon Muller; Diederick E Grobbee; Isolde den Tonkelaar; Steven W J Lamberts; Yvonne T van der Schouw Journal: J Clin Endocrinol Metab Date: 2005-02-01 Impact factor: 5.958
Authors: R D Abbott; L J Launer; B L Rodriguez; G W Ross; P W F Wilson; K H Masaki; D Strozyk; J D Curb; K Yano; J S Popper; H Petrovitch Journal: Neurology Date: 2007-02-20 Impact factor: 9.910
Authors: Michael B Cook; Shannon N Wood; Brooks D Cash; Patrick Young; Ruben D Acosta; Roni T Falk; Ruth M Pfeiffer; Nan Hu; Hua Su; Lemin Wang; Chaoyu Wang; Barbara Gherman; Carol Giffen; Cathy Dykes; Veronique Turcotte; Patrick Caron; Chantal Guillemette; Sanford M Dawsey; Christian C Abnet; Paula L Hyland; Philip R Taylor Journal: Clin Gastroenterol Hepatol Date: 2014-08-24 Impact factor: 11.382
Authors: K K Tsilidis; S Rohrmann; K A McGlynn; S J Nyante; D S Lopez; G Bradwin; M Feinleib; C E Joshu; N Kanarek; W G Nelson; E Selvin; E A Platz Journal: Andrology Date: 2013-09-30 Impact factor: 3.842
Authors: Andre B Araujo; Julia M Dixon; Elizabeth A Suarez; M Hassan Murad; Lin T Guey; Gary A Wittert Journal: J Clin Endocrinol Metab Date: 2011-08-03 Impact factor: 5.958
Authors: M B Cook; S Wood; P L Hyland; P Caron; J Drahos; R T Falk; R M Pfeiffer; S M Dawsey; C C Abnet; P R Taylor; C Guillemette; L J Murray; L A Anderson Journal: Andrology Date: 2017-02-27 Impact factor: 3.842
Authors: Margaret A Gates; Rania A Mekary; Gretchen R Chiu; Eric L Ding; Gary A Wittert; Andre B Araujo Journal: J Clin Endocrinol Metab Date: 2013-04-26 Impact factor: 5.958
Authors: Jessica L Petrick; Paula L Hyland; Patrick Caron; Roni T Falk; Ruth M Pfeiffer; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Susan M Gapstur; Gary Bradwin; Chantal Guillemette; Peter T Campbell; Michael B Cook Journal: J Natl Cancer Inst Date: 2019-01-01 Impact factor: 13.506
Authors: Marcello Maggio; Peter J Snyder; Francesca De Vita; Gian Paolo Ceda; Yuri Milaneschi; Fulvio Lauretani; Michele Luci; Chiara Cattabiani; Helen Peachey; Giorgio Valenti; Anne R Cappola; Dan L Longo; Luigi Ferrucci Journal: Endocr Pract Date: 2014-11 Impact factor: 3.443